Assystem - 2018 Register document

1

PRESENTATION OF THE GROUP

HISTORY

France, Belgium and Switzerland. At 31 December 2018, Assystem owned 96.8% of the share capital of Assystem Care Holding, which in turn wholly owns three operating subsidiaries that are dedicated to the French, Belgian and Swiss markets respectively. ● The purchase (in late 2017) of the entire capital of the French company, Euro Contrôle Projet (ECP). ECP is specialised in the Project Management Office (PMO) concept and covers the entire spectrum of corresponding services, i.e. planning and cost optimisation as well as risk, contract and quality management. This acquisition – like that of Onyx Promavi in 2016 – has rounded out Assystem’s project management offering. ● The purchase (in late 2018) of the entire capital of the French company E-P6 Consulting, which specialises in integrating project management software. This acquisition further strengthened Assystem’s project management offering, led by its subsidiary Euro Contrôle Projet (ECP), which is specialized in the Project Management Office (PMO) concept, covering planning and cost optimization as well as risk, contract and quality management.

Assystem to strengthen its ties with France’s key nuclear participants while leaving it entirely free to continue its projects with other major international players. ACQUISITIONS IN THE LIFE SCIENCES AND PROJECT MANAGEMENT SECTORS Drawing on the expertise it has built up in managing complex projects subject to significant regulatory constraints as well as the advances made in robotics and digitisation of engineering services, Assystem has continued to expand its business through both organic and acquisition- led growth in the transport infrastructure, life sciences, and project management markets. In 2017 and 2018, it made the following three acquisitions to expand its business in two of those markets: ● The purchase (in late 2017) of a 72.7% interest in The Biotech Quality Group (TBQG) – a Belgian consulting firm that specialises in performance management and improving regulatory compliance in Europe’s pharmaceutical and biotech industries. TBQG’s activities were combined with Assystem E&I’s life sciences business in 2018 to create Assystem Care, which operates in the life sciences sector in

10

ASSYSTEM

REGISTRATION DOCUMENT 2018